TTX’s Advanced Manufacturing Facility
Tetratherix has developed a biostealth fluid matrix that evolves regenerative medicine
Our mission is to use the Tetramatrix™ platform technology to help treat 10 million patients by 2035 by developing therapies, solutions and products that enable the future of healthcare delivery
10,000,000
People
Global
Reach
10
Years (By 2035)
